Carbinoxamine Maleate Patent Expiration

Carbinoxamine Maleate was first introduced by Mcneil Pharmaceutical Co Div Mcneilab Inc in its drug Clistin on Approved Prior to Jan 1, 1982. Another drug containing Carbinoxamine Maleate is Karbinal Er. 11 different companies have introduced drugs containing Carbinoxamine Maleate.


Carbinoxamine Maleate Patents

Given below is the list of patents protecting Carbinoxamine Maleate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Karbinal Er US8062667 Modified release formulations containing drug-ion exchange resin complexes Mar 29, 2029 Aytu
Karbinal Er US9522191 Modified release formulations containing drug—ion exchange resin complexes Jun 15, 2027 Aytu



Carbinoxamine Maleate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Carbinoxamine Maleate Generic API Manufacturers

Several generic applications have been filed for Carbinoxamine Maleate. The first generic version for Carbinoxamine Maleate was by Genus Lifesciences Inc and was approved on Mar 19, 2003. And the latest generic version is by Leading Pharma Llc and was approved on Dec 19, 2024.

Given below is the list of companies who have filed for Carbinoxamine Maleate generic, along with the locations of their manufacturing plants worldwide.